Cas No.: | 1227634-69-6 |
Chemical Name: | N-(2-(3H-Indol-3-yl)ethyl)-9-isopropyl-2-(5-methyl-3-pyridyl)-7H-purin-6-amine |
Synonyms: | GNF 351;GNF351 |
SMILES: | N1C2C(=NC(C3=CC(C)=CN=C3)=NC=2NCCC2C3=C(N=C2)C=CC=C3)N(C(C)C)C1 |
Formula: | C24H25N7 |
M.Wt: | 411.5 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Publication: | 1. Smith KJ, et al. J Pharmacol Exp Ther. 2011 Jul;338(1):318-27. 2. Fang ZZ, et al. Br J Pharmacol. 2014 Apr;171(7):1735-46. 3. DiNatale BC, et al. Mol Cancer Res. 2012 Oct;10(10):1369-79. |
Description: | A potent, pure aryl hydrocarbon receptor (AHR) antagonist (IC50=62 nM) devoid of partial agonist potential; antagonizes agonist and SAhRM-mediated suppression of SAA1, inhibit both DRE-dependent and -independent activity; decreases migration and invasion of HNSCC cells and prevents benzo[a]pyrene-mediated induction of the chemotherapy efflux protein ABCG2. |